American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2019, 7(7), 148-150
DOI: 10.12691/ajmcr-7-7-8
Open AccessCase Report

An Unexpected Pregnancy Test Result Leading to the Diagnosis of Advanced Gastric Cancer

Jordonna Brown1, Odeth Barrett-Campbell1, Yakira David1, Carol Luhrs2 and Samy I. McFarlane1,

1Division of Medicine, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA

2Division of Hematology and Oncology, Veterans Affairs New York Harbor Healthcare System, Brooklyn, NY 11209, USA

Pub. Date: July 05, 2019

Cite this paper:
Jordonna Brown, Odeth Barrett-Campbell, Yakira David, Carol Luhrs and Samy I. McFarlane. An Unexpected Pregnancy Test Result Leading to the Diagnosis of Advanced Gastric Cancer. American Journal of Medical Case Reports. 2019; 7(7):148-150. doi: 10.12691/ajmcr-7-7-8

Abstract

The presence of beta human chorionic gonadotropin in the absence of pregnancy warrants further work-up as elevated levels may be seen in trophoblastic disease or germ cell tumors and rarely in solid tumors such as gastric cancers. The signs and symptoms of gastric cancer are vague and as such, the diagnosis is often delayed. Overexpression of the beta-subunit of human chorionic gonadotrophin may be seen in close to 50% of gastric cancers. The implication of this finding is unclear; however, beta human chorionic gonadotropin reactivity may play a role in tumorigenesis and often correlates with an advanced stage at presentation. Herein, we present a case report of a patient with an incidental finding of a positive urinary human chorionic gonadotropin test which led to the diagnosis of advanced gastric cancer.

Keywords:
gastric cancer tumor markers βHCG non-pregnant

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Zali H, Rezaei-Tavirani M & Azodi M: Gastric cancer: Prevention, risk factors and treatment. Gastroenterology and Hepatology from Bed to Bench 2011; 4 (4): 175-185.
 
[2]  Jiexian J, Xiaoqin X, Lili D, Baoguo T, Ting S, Xianwen Z & Cunzhi H: Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. International Journal of Biological Markers 2013; 28 (2): 192-200.
 
[3]  Birkenfeld, S, Noiman, G, Krispin, M, Schwartz, S, Zakut, H: The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors. European Journal of Surgical Oncology 1989; 15 (2): 103-8.
 
[4]  World Health Organization. Stomach cancer estimated incidence, mortality and prevalence worldwide in 2012, http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (n.d)
 
[5]  Blaser MJ. Hypothesis: The changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999; 179(6): 1523-30.
 
[6]  Walker L & Erler B: Gastric cancer in the setting of Persistently elevated human chorionic gonadotropin: A case report. Case Reports in Obstetrics and Gynecology, 2011; 2011: 1-4.